Hydrocortisone and Tambocor drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Hydrocortisone (hydrocortisone) and Tambocor (flecainide acetate). Common drug interactions include asthma among females and cardiac failure among males.

The phase IV clinical study analyzes what interactions people have when they take Hydrocortisone and Tambocor. It is created by eHealthMe based on reports of 15 people who take the same drugs from the FDA, and is updated regularly.

What is Hydrocortisone?

Hydrocortisone has active ingredients of hydrocortisone. It is often used in addison's disease. eHealthMe is studying from 40,425 Hydrocortisone users. Check the latest studies of Hydrocortisone.

What is Tambocor?

Tambocor has active ingredients of flecainide acetate. It is often used in atrial fibrillation/flutter. eHealthMe is studying from 2,621 Tambocor users. Check the latest studies of Tambocor.



On Jul, 20, 2026

15 people who take Hydrocortisone and Tambocor together, and have interactions are studied.

Hydrocortisone and Tambocor drug interactions.

What are the common drug interactions of Hydrocortisone and Tambocor, by gender? *:

female:

  1. Asthma
  2. Chronic kidney disease
  3. Demyelination (loss of the myelin covering of some nerve fibres resulting in their impaired function)
  4. Dental care
  5. Epicondylitis (tennis elbow)
  6. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  7. Rash
  8. Restless legs syndrome (a powerful urge to move your legs)
  9. Thrombocytosis
  10. Tinnitus (a ringing in the ears)

male:

  1. Cardiac failure
  2. Dementia (madness)
  3. Fall
  4. Hallucination, visual (seeing things that aren't there)
  5. Hip fracture
  6. Hypertension (high blood pressure)
  7. Memory impairment
  8. Parkinson's disease
  9. Cardiac disorder

What are the common drug interactions of Hydrocortisone and Tambocor, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Abdominal pain
  2. Arthralgia (joint pain)
  3. Eructation (release of gas from the digestive tract)
  4. Nausea (feeling of having an urge to vomit)
  5. Oesophagitis (inflammation of oesophagus)

40-49:

n/a

50-59:

  1. Asthma
  2. Chronic kidney disease
  3. Demyelination (loss of the myelin covering of some nerve fibres resulting in their impaired function)
  4. Dental care
  5. Epicondylitis (tennis elbow)
  6. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  7. Rash
  8. Restless legs syndrome (a powerful urge to move your legs)
  9. Thrombocytosis
  10. Tinnitus (a ringing in the ears)

60+:

  1. Abdominal pain
  2. Cardiac failure
  3. Parkinson's disease
  4. Amyloidosis (a tumour within which amyloid is produced)
  5. Blood creatine increased
  6. Cardiac disorder
  7. Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
  8. Cryptogenic organizing pneumonia (small airways (bronchioles) and air exchange sac (alveoli) become inflamed with connective tissue)
  9. Cytokine release syndrome (immediate complication occurring with the use of anti-t cell antibody infusions)
  10. Dyspnoea (difficult or laboured respiration)

What are the existing conditions these people have? *

  1. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 4 people, 26.67%
  2. Joint Pain: 4 people, 26.67%
  3. Hypopituitarism (diminished hormone secretion by the pituitary gland, causing dwarfism in children and premature aging in adults): 4 people, 26.67%
  4. Primary Hypothyroidism (failure of the thyroid gland to produce or release thyroid hormones into the bloodstream): 3 people, 20.00%
  5. Galactosaemia (transformation of galactose to glucose is blocked): 2 people, 13.33%
  6. Dyspnea (difficult or laboured breathing): 2 people, 13.33%
  7. Blood Follicle Stimulating Hormone Decreased: 2 people, 13.33%
  8. Blood Luteinising Hormone Decreased: 2 people, 13.33%
  9. Blood Thyroid Stimulating Hormone Decreased: 2 people, 13.33%
  10. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 2 people, 13.33%

* Approximation only. Some reports may have incomplete information.

Do you take Hydrocortisone and Tambocor?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Hydrocortisone and Tambocor:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Hydrocortisone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Tambocor:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Hydrocortisone and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Tambocor and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on hydrocortisone and flecainide acetate (the active ingredients of Hydrocortisone and Tambocor, respectively), and Hydrocortisone and Tambocor (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: